default author photo

Ralph S. Baric

University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology

United States

SCHOLARLY PAPERS

2

DOWNLOADS

159

TOTAL CITATIONS

12

Scholarly Papers (2)

1.

Universal Immune Predictors of Mortality Following Virus Infection

Number of pages: 29 Posted: 05 Jun 2019
Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Genetics, University of North Carolina (UNC) at Chapel Hill - Department of Genetics, University of Washington, University of Washington, Oregon Health and Science University - Division of Bioinformatics and Computational Biology, Oregon Health and Science University - Oregon Clinical and Translational Research Institute, University of North Carolina (UNC) at Chapel Hill - Department of Genetics, Oregon Health and Science University - Division of Bioinformatics and Computational Biology, Oregon Health and Science University - Division of Bioinformatics and Computational Biology, University of North Carolina (UNC) at Chapel Hill - Department of Genetics, University of North Carolina (UNC) at Chapel Hill - Department of Genetics, University of Washington, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Genetics and Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division
Downloads 116 (613,149)

Abstract:

Loading...

Immune predictors, Collaborative Cross, Virus infections, Mortality to virus infection

2.

Remdesivir Potently Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

Number of pages: 28 Posted: 11 May 2020
Vanderbilt University - Department of Pediatrics, Vanderbilt University - Department of Pediatrics, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Vanderbilt University - Department of Pediatrics, Vanderbilt University - Department of Pediatrics, Vanderbilt University - Department of Pediatrics, Vanderbilt University - Department of Pediatrics, Vanderbilt University - Department of Pediatrics, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., Gilead Sciences, Inc., University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Vanderbilt University - Department of Pediatrics and University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology
Downloads 43 (1,145,425)
Citation 12

Abstract:

Loading...

COVID-19, SARS-Cov-2, coronavirus, antivirals, remdesivir, RdRp, RNA-dependent RNA polymerase, therapeutic, mouse